Natural History: HCV symptoms, disease progression and
1612. Relationship of Iron [Fe] and
HFE genetic variations to progression and outcomes of advanced chronic hepatitis
C in the HALT-C Trial.
1613. Aging of Hepatitis C Infected
Persons in the United States: A Multiple Cohort Model of HCV Prevalence and
Disease Progression. (updated Nov
1617. Incidence of end-stage liver
disease and death among 585 HIV/HCV coinfected adults according to baseline
fibrosis stage. (updated Nov
1620. Validation of a panel of
genetic markers (CRS7) in predicting cirrhosis, fibrosis progression (FP) and
clinical outcomes in patients with chronic hepatitis C (CHC) in the HALT-C
1622. Insulin Resistance and Hepatic
Steatosis are Both Independently Associated with Advanced Hepatic Fibrosis in
Chronic Hepatitis C Infection: Analysis of the ACHIEVE 1 and ACHIEVE 2/3
1625. Serum fibrosis markers are
associated with clinical outcomes and histological progression in patients with
chronic hepatitis C (CHC) and advanced fibrosis.
1626. Chronic Hepatitis C Infection
is Associated with Lower Rates of Hospitalization for Coronary Heart Disease.
1627. Hepatic Impairment Measured by
Quantitative Tests of Liver Function (QLFTs) Predicts Clinical Outcome in
Patients with Advanced Fibrosis: Results from the Hepatitis C Antiviral
Long-Term Treatment against Cirrhosis (HALT-C) Trial.
1650. Long-term evaluation of
fibrosis by Transient Elastography in patients clearing HCV on antiviral therapy.
1655. Quantitative HCV core antigen
and HCV-RNA kinetics in HCV infected patients over a period of up to 8 years.
1656. The Extent of Liver Fibrosis
Measured Using Transient Elastometry Predicts Mortality in HIV Patients with
1657. Amino acid substitutions in the
hepatitis C virus core region were induced by aging and severe hepatic
1658. Semen Characteristics In
Hepatitis C Virus (HCV) Infected Patients. Relationship Between Semen
Characteristics And Assisted Reproduction Technologies (ART) Practice. (updated Nov 5, 2009)
1659. Excessive alcohol intake
drastically impacts transplant-free survival: a longitudinal study in HCV
cirrhotic patients (updated Nov
1663. Prediction of HCV-related
mortality in Belgium using a mathematical modeling approach: impact of current
treatment practice and different scenarios improving screening, access to
treatment and treatment efficacy.
Natural clearance of hepatitis C virus (HCV) RNA in chronic HCV carriers: A
long-term cohort study in an endemic area of HCV infection in Japan.
Early spontaneous resolution of acute hepatitis C depends on the HCV genotypes
and the levels of HCV RNA.
Paired Biopsies Illustrate Racial Differences in Fibrosis Progression in HCV
Age, Insulin Resistance and Steatosis are Independent Risk Factors for Fibrosis
Progression in Untreated Patients with Mild Chronic Hepatitis C: A Prospective
Study with Repeat Biopsies. (updated Nov 13, 2009)
Hepatic fibrosis regression in the setting of persistent viremia in chronic
hepatitis C: a dual biopsy study.
Diagnosis of occult HCV infection without performing a liver biopsy.
Quality of Life
Resilience affects the quality of life in patients with chronic hepatitis C.
(updated Nov 5, 2009)
§ 1645. Self-reported cognitive
symptoms are commonly associated with underlying neurocognitive impairment in
hepatitis C infected patients referred for antiviral treatment. (updated Nov 5, 2009)
1615. Early loss of exposure to
Estrogens is critical in determining entity of fibrosis and response to IFN in
women with hepatitis C.
1631. Hepatitis C and menopause:
interplay of age, gender, HCV replication and activity in progression and
consequence for therapy. (updated Nov 13, 2009)